A Literature Review: Management of Paralysis and Prevention of Acute Respiratory Failure in Guillain-Barré Syndrome
DOI:
10.29303/jbt.v26i3.12588Published:
2026-07-09Downloads
Abstract
Guillain-Barré Syndrome (GBS) is an acute immune-mediated disorder of the peripheral nervous system characterized by progressive muscle weakness and paralysis. In severe cases, respiratory muscle involvement may lead to acute respiratory failure, which remains one of the leading causes of morbidity and mortality in patients with GBS. This literature review aims to discuss the pathophysiology, clinical manifestations, diagnostic approaches, management of paralysis, and strategies for preventing acute respiratory failure in Guillain-Barré Syndrome. A literature review was conducted by analyzing scientific journal articles, textbooks, and international clinical guidelines retrieved from electronic databases. The findings indicate that GBS is the most common cause of acute non-traumatic flaccid paralysis worldwide and is frequently preceded by an infectious illness. Diagnosis is primarily established based on clinical features and supported by cerebrospinal fluid analysis and electrodiagnostic studies, with diagnostic certainty commonly assessed using the Brighton Collaboration Criteria and clinical evaluation guided by the National Institute of Neurological Disorders and Stroke (NINDS) criteria. Respiratory complications occur in approximately 20–30% of patients and often require intensive monitoring and mechanical ventilation. Early recognition of respiratory muscle weakness through serial assessment of respiratory function, prompt airway management, and timely ventilatory support are essential to prevent acute respiratory failure and improve clinical outcomes. A multidisciplinary approach involving neurologists, intensivists, pulmonologists, rehabilitation specialists, and nursing teams is crucial for reducing morbidity and mortality associated with GBS.
Keywords:
Acute respiratory failure Guillain-Barré Syndrome Mechanical ventilation Paralysis Respiratory managementReferences
Adam, O. M. (2011). Guillain-Barré syndrome. Hang Tuah Medical Journal, 9(3), 124–133.
Algahtani, H., Shirah, B., Alassiri, A., & Madkhali, A. (2021). Guillain-Barré syndrome: Clinical features, diagnostic approaches, and therapeutic strategies. Neurosciences (Riyadh), 26(3), 175–183.
Elendu, C., Osamuyi, E. I., Afolayan, I. A., Opara, N. C., Chinedu-Anunaso, N. A., Okoro, C. B., ... & Peterson, J. C. (2024). Clinical presentation and symptomatology of Guillain-Barré syndrome: A literature review. Medicine, 103(30), e38890. Elendu, C. et al. (2024) ‘Clinical presentation and symptomatology of Guillain-Barré syndrome: A literature review’, Medicine (United States), 103(30), p. e38890. Available at: https://doi.org/10.1097/MD.0000000000038890.
Fokke, C., van den Berg, B., Drenthen, J., Walgaard, C., van Doorn, P. A., & Jacobs, B. C. (2014). Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain, 137(1), 33–43.
Hauser, S. L., & Asbury, A. K. (2005). Guillain-Barré syndrome and other immune-mediated neuropathies. Harrisons Principles of Internal Medicine, 16(2), 2513.Hauser SL, Loscalzo joseph. Guillain-Barré Syndrome And Other Immune-Mediated Neuropathies. In: Hauser SL., Amato A, editors. Harrison’s neurology in clinical medicine. 3rd ed. McGraw-Hill education; 2013. p. 599–608.
Hughes, R. A., Swan, A. V., & van Doorn, P. A. (2010). Corticosteroids for guillain‐barré syndrome. Cochrane Database of Systematic Reviews, (2).Hughes RA, Swan A V, van Koningsveld R, van Doorn PA. Corticosteroids for Guillain-Barré syndrome. In: Hughes RA, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 2009.
Khan, F., Amatya, B., & Ng, L. (2019). Rehabilitation in Guillain-Barré syndrome. Cochrane Database of Systematic Reviews.
Khan, F., Amatya, B., & Ng, L. (2019). Use of ventilatory support in Guillain–Barré syndrome. European Journal of Neurology, 26(8), 1062–1070.
Liu, S., Chu, H., Peng, B., Zeng, Y., Liu, J., Lu, Z., & Weng, C. (2025). Clinical and electrophysiological features of pure sensory Guillain-Barré syndrome: retrospective analysis of 22 patients across 14 provinces in Southern China. BMC neurology, 25(1), 87.
Liu, S., Chu, H., Peng, B., Zeng, Y., Liu, J., Lu, Z., & Weng, C. (2025). Clinical and electrophysiological features of pure sensory Guillain-Barré syndrome: retrospective analysis of 22 patients across 14 provinces in Southern China. BMC neurology, 25(1), 87. https://doi.org/10.1186/s12883-025-04103-w.
Panduan Praktik Klinis Neurologi Perhimpunan Dokter Spesialis Saraf Indonesia (2016).
Papazian, L., Klompas, M., & Luyt, C. E. (2020). Ventilator-associated pneumonia in adults: a narrative review. Intensive care medicine, 46(5), 888-906.Papazian, L., Klompas, M., & Luyt, C. E. (2020). Ventilator-associated pneumonia in adults: A narrative review. Intensive Care Medicine, 46(5), 888–906.
Putri, G. H. G., Yasmin, N. N. R., & Kurniawan, S. N. (2023). Guillain-barré syndrome. Journal of Pain, Headache and Vertigo, 4(2), 46-50. Hanandita, G. et al. (2023) ‘Guillain-Barré Syndrome’, pp. 46–50. Available at: https://doi.org/10.21776/ub.jphv.2023.004.02.4.
Rabinstein, A. A. (2015). Acute neuromuscular respiratory failure. CONTINUUM: Lifelong Learning in Neurology, 21(5, Neurocritical Care), 1324-1345.Rabinstein, A. A. (2016). Acute neuromuscular respiratory failure. Continuum: Lifelong Learning in Neurology, 22(5), 1321–1344.
Rahman, R. S., Bauthman, M. S., Alanazi, A. M., Alsillah, N. N., Alanazi, Z. M., Almuhaysin, M. I., ... & Alrawili, O. N. (2021). Guillain--Barré syndrome: pathophysiology, etiology, causes, and treatment. Int J Community Med Public Health, 8, 3624-8.Rahman RS, Bauthman MS, Alanazi AM, Alsillah NN, Alanazi ZM, Almuhaysin MI, et al. (2021). Guillain–Barré syndrome: pathophysiology, etiology, causes, and treatment. International Journal of Community Medicine and Public Health, 8(7), 3624–3628. https://doi.org/10.18203/2394-6040.ijcmph20212324
Safri A, Wiratman W, Indrawati L, Octaviana F, Hakim M. Sindrom Guillain Barre. In: Aninditha T, Haris S, Winnugroho W, editors. Buku Ajar Neurologi. 2nd ed. Jakarta: Departemen Neurologi Fakultas Kedokteran Universitas Indonesia Rumah Sakit Cipto Mangunkusumo; 2022. p. 804–16.
Shahrizaila, N., Lehmann, H. C., & Kuwabara, S. (2021). Guillain-barré syndrome. The lancet, 397(10280), 1214-1228.Shahrizaila N, Lehmann HC, Kuwabara S. (2021). Guillain-Barré syndrome. The Lancet, 397(10280), 1214–1228. https://doi.org/10.1016/S0140-6736(21)00517-1
Shahrizaila, N., Lehmann, H. C., & Kuwabara, S. (2021). Guillain-Barré syndrome. The Lancet, 397(10280), 1214–1228.
Van den Bergh, P. Y. K., van Doorn, P. A., Hadden, R. D. M., et al. (2023). European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome. Journal of the Peripheral Nervous System.
Walgaard, C., Lingsma, H. F., Ruts, L., Drenthen, J., van Koningsveld, R., Garssen, M. J., ... & Jacobs, B. C. (2010). Prediction of respiratory insufficiency in Guillain‐Barré syndrome. Annals of neurology, 67(6), 781-787.Walgaard C, Lingsma HF, Ruts L, Drenthen J, van Koningsveld R, Garssen MJP, et al. Prediction of respiratory insufficiency in Guillain‐Barré syndrome. Ann Neurol. 2010 Jun 25;67(6):781–7.
Wen, P., Wang, L., Liu, H., Gong, L., Ji, H., Wu, H., & Chu, W. (2021). Risk factors for the severity of Guillain-Barré syndrome and predictors of short-term prognosis of severe Guillain-Barré syndrome. Scientific Reports, 11(1), 11578.Wen P, Wang L, Liu H, Gong L, Ji H, Wu H, Chu W. (2021). Risk factors for the severity of Guillain-Barré syndrome and predictors of short-term prognosis of severe Guillain-Barré syndrome. Scientific Reports, 11, 11578. https://doi.org/10.1038/s41598-021-91132-3
Willison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016). Guillain-barre syndrome. The Lancet, 388(10045), 717-727.Willison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016). Guillain-Barré syndrome. The Lancet, 388(10045), 717–727.
Willison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016). Guillain-Barré syndrome. The Lancet, 388(10045), 717–727.
Yuki, N., & Hartung, H. P. (2012). Guillain–barré syndrome. New England Journal of Medicine, 366(24), 2294-2304.Yuki N, Hartung HP. Guillain–Barré Syndrome. New England Journal of Medicine. 2012 Jun 14;366(24):2294–304.
Zhong, X., Chang, Y., Tan, S., Wang, J., Sun, X., Wu, A., ... & Qiu, W. (2019). Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome. BMC neurology, 19(1), 94.
License
Copyright (c) 2026 Ahmad Sa'Bi Al Qindi, Cantika Brilliant Senna, Muhammad Hilmy As Shiddiq, Moh. Rizky Yolanda B.S, Yasmin Sabrina Zulkifli, Prima Belia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
